Carcinogenesis in the biliary system associated with APDJ

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 6, Issue 3, 1999, Pages 218-222

  Chao, Tzu Chieh ^a,b   Wang, Chia Siu ^a,b   Jan, Yi Yin ^a,b   Chen, Han Ming ^a,b   Chen, Miin Fu ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Bile duct; Carcinoma; Gallbladder; K ras; p53

Indexed keywords

ADENOCARCINOMA; COMMON BILE DUCT; CONGENITAL MALFORMATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GALLBLADDER TUMOR; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; ONCOGENE RAS; PANCREAS DUCT; PATHOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; COMMON BILE DUCT; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION; GENES, P53; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PANCREATIC DUCTS; SENSITIVITY AND SPECIFICITY;

EID: 0033286144     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340050110     Document Type: Article

References (56)

1. Yamauchi S, Koga A, Matsumoto S, Tanaka M, Nakayama F (1987) Anomalous junction of pancreaticobiliary duct without congenital cyst: a possible risk factor for gallbladder cancer. Am J Gastroenterol 82:20-24.
2. Wang H-P, Wu M-S, Lin C-C, Chang L-Y, Kao A-W, Wang H-H, Lin J-T (1998) Pancreaticobiliary diseases associated with anomalous pancreaticobiliary ductal union. Gastrointest Endosc 48:184-189
3. Chao T-C, Jan Y-Y, Chen M-F (1995) Primary carcinoma of the gallbladder associated with anomalous pancreaticobiliary ductal junction. J Clin Gastroenterol 21:306-308
4. Suda K, Miyano T, Konuma I, Matsumoto M (1983) An abnormal pancreatico-choledocho-ductal junction in cases of biliary tract carcinoma. Cancer 52:2086-2088
5. Kimura K, Ohto M, Saisho H, Unozawa T, Tsuchiya Y, Morita M, Ebara M, Matsutani S, Okuda K (1985) Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology 89:1258-1265
6. Kinoshita H, Nagata E, Hirohashi K, Sakai K, Kobayashi Y (1984) Carcinoma of the gallbladder with an anomalous connection between the choledochus and the pancreatic duct. Cancer 54:762-769
7. Nagata E, Sakai K, Kinoshita H, Kobayashi Y (1985) The relation between carcinoma of the gallbladder and an anomalous connection between the choledochus and the pancreatic duct. Ann Surg 202:182-190
8. Todani K, Ikoma A, Hamada N, Nishida S, Kadono J, Taira A (1998) Biliary tract cancer accompanied by anomalous junction of pancreaticobiliary ductal system in adults. Am J Surg 175:218-220
9. Tanaka K, Nishimura A, Yamada K, Ishibe R, Ishizaki N, Yoshimine M, Hamada N, Taira A (1993) Cancer of the gallbladder associated with anomalous junction of the pancreaticobiliary duct system without bile duct dilatation. Br J Surg 80:622-624
10. Todani T, Tabuchi K, Watanabe Y, Kobayashi T (1979) Carcinoma arising in the wall of congenital bile duct cysts. Cancer 44:1134-1141
11. Chijiiwa K, Kimura H, Tanaka M (1995) Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction: the difference in risk between patients with or without choledochal cyst. Int Surg 80:61-64
12. Matsubara T, Tsuji T, Miyama A, Yamaguchi H, Funabiki T (1995) Mutagenicity of bile and pancreatic juice from patients with pancreatico-biliary maljunction. Hepatogastroenterology 42:113-116
13. Mizuno M, Kato T, Koyama K (1996) An analysis of mutagens in the contents of the biliary tract in pancreaticobiliary maljunction. Surg Today 26:597-602
14. Reveille RM, van Stiegmann G, Everson GT (1990) Increased secondary bile acids in a choledochal cyst: possible role in bilary metaplasia and carcinoma. Gastroenterology 99:525-527
15. Kinami Y, Miyakoshi M, Fujikawa K (1998) Bile acid load on the DNA distribution pattern of bile ductules and cholangiocarcinoma induced by diisopropanolnitrosamine in hamsters. Oncology 55:77-86
16. Shimada K, Chijiiwa K, Yanagisawa J, Nakayama F (1993) Biliary bile acids in the gall-bladder and the common bile duct of patients with anomalous pancreaticobiliary ductal junction. J Gastroenterol Hepatol 8:138-141
17. Shimada K, Yanagisawa J, Nakayama F (1991) Increased lyophosphatidylcholine and pancreatic enzyme content in bile of patients with anomalous pancreaticobiliary ductal junction. Hepatology 13:438-444
18. Matsubara T, Sakurai Y, Sasayama Y, Haruna H, Ochiai M, Funabiki T, Matsumoto K, Hirono I (1996) K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. Cancer 77:1752-1757
19. Tokiwa K, Iwai N (1996) Early mucosal changes of the gallbladder in patients with anomalous arrangement of the pancreaticobiliary duct. Gastroenterology 110:1614-1618
20. Oguchi Y, Okada A, Nakamura T, Okumura K, Miyata M, Nakao K, Kawashima Y (1988) Histopathologic studies of congenital dilatation of the bile duct as related to an anomalous junction of the pancreaticobiliary ductal system: clinical and experimentaal studies. Surgery 103:168-173
21. Kaneko K, Ando H, Umeda T, Murahashi O, Hiraiwa K, Niimi N, Hossain M, Ito T (1996) A new model for pancreaticobiliary maljunction without bile duct dilatation: demonstration of cell proliferation in the gallbladder epithelium. J Surg Res 60:115-121
22. Benhidjeb T, Said S, Rudolph B, Siegmund E (1996) Anomalous pancreatico-biliary junction - report of a new experimental model and review of the literature. J Pediatr Surg 31:1670-1674
23. Tanno S, Obara T, Fujii T, Mizukami Y, Shudo R, Nishino N, Ura H, Klein-Szanto AJP, Kohgo Y (1998) Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer 83:267-275
24. Konzuka S, Kurashina M, Tsubone M, Hachisuka K, Yasui A (1984) Significance of intestinal metaplasia for the evolution of cancer in the biliary tract. Cancer 54:2277-2285
25. Yamamoto M, Nakajo S, Tahara E, Ito M, Taniyama K, Shimamoto F, Miyoshi N, Hayashi Y, Skiyama H, Nakai S (1991) Mucosal changes of the gallbladder in anomalous union with the pancreaticobiliary duct system. Pathol Res Pract 187:241-246
26. Miyano T, Tokumaru T, Suzuki F, Suda K (1989) Adenoma and stone formation of the biliary tract in puppies that had choledochopancreatic anastomosis. J Pediatr Surg 24:539-542
27. 2 stimulates the growth of human pancreatic cancer cell line. FEBS Lett 373:85-87
28. 2 in Swiss 3T3 cells via specific binding site. J Biol Chem 266:19139-19141
29. 2 in the rat. J Biol Chem 267:6414-6420
30. Sedlis SP, Sequeira JM, Ahumada GG, Sherif NE (1988) Effects of lysophosphatidylcholine on cultured heart cells: correlation of rate of uptake and extent of accumulation with cell injury. J Lab Clin Med 112:745-754
31. Weltzien HU (1979) Cytolytic and membrane-perturbing properties of lysophosphatidylcholie. Biochim Biophys Acta 559:259-287
32. Bos JL (1989) ras Oncogenes in human cancer: a review. Cancer Res 49:4682-4689
33. Barbacid M (1987) ras genes. Annu Rev Biochem 56:779-827
34. Watanabe H, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T (1994) Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1087:1147-1153
35. Imai M, Hoshi T, Ogawa K (1994) K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer 73:2727-2733
36. Rijken AM, van Gulik T, Polak M, Sturm PDJ, Gouma DJ, Offerhaus GJA (1988) Diagnostic and prognostic value of incidence of K-ras codon 12 mutations in resected distal bile duct carcinoma. J Surg Oncol 68:187-192
37. Ohashi K, Tsutsumi M, Nakajima Y, Nakano H, Konishi Y (1996) K-ras point mutations and proliferation activity in biliary tract carcinomas. Br J Cancer 74:930-935
38. Hanada K, Itoh M, Fujii K, Tsuchida A, Ooishi H, Kajiyama G (1996) K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer 77:452-458
39. Iwase T, Nakazawa S, Yamao K, Yoshino J, Inui K, Yamachika H, Kanemaki N, Fujimoto M, Okushima K, Miyoshi H, Tkai N, Nakamura Y, Mizutani S, Horibe Y, Masui T, Tatematsu M (1997) Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts. Hepatogastroenterology 44:1457-1462
40. Majima T, Tsujiuchi T, Tsutsumi M, Tasunoda T, Konishi Y (1997) Mutations of K-ras but not p53 genes in biliary duct and pancreatic duct carcinomas induced in hamsters by cholecystoduodenostomy with dissection of the common duct followed by N-nitrosobis (2-oxopropyl) amine. Cancer Lett 118:47-53
41. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 252:49-53
42. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature 342:705-708
43. Wistuba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I, Albores-Saavedra J, Gazdar AF (1995) Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 55:2511-2515
44. Wee A, Teh M, Raju GC (1994) Clinical importance of p53 protein in gallbladder carcinoma and its precursor lesions. J Clin Pathol 47:453-456
45. Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J (1996) p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 27:360-365
46. Washington K, Gottfried MR (1996) Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver 16:99-104
47. Roa I, Villaseca M, Araya J, Roa J, de Aretxabala X, Melo A, Ibacache G (1997) p53 tumor suppressor gene protein expression in early and advanced gallbladder carcinoma. Histopathology 31:226-230
48. Ajiki T, Onoyama H, Yamamoto M, Asaka K, Fujimori T, Maeda S, Saitoh Y (1996) p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. Hepatogastroenterology 43:521-526
49. Akiyama T, Hasegawa T, Sejima T, Sahara H, Kitabayashi K, Seto K, Saito H, Takashima S (1997) Anomalous junction of the pancreaticobiliary duct accompanied by gallbladder cancer and obstructive jaundice in a patient with high serum and bile cytokine levels. J Gastroenterol 33:597-601
50. Billadeau D, Jelinek DF, Shah N, LeBien TW, Van Ness B (1995) Induction of an activated N-ras oncogen alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6. Cancer Res 55:3640-3646
51. Siegall CB, Schwab G, Nordan RP, FitzGerald DJ, Pastan I (199) Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 50:7786-7788
52. Lotz M (1993) Interleukin-6. Cancer Invest 11:732-742
53. Akira S, Hirano T, Taga T, Kishimoto T (1990) Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 4:2860-2867
54. Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RC Jr (1993) Tumor necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor α expression. Cancer Res 53:1939-1944
55. Orosz P, Echtenacher B, Falk W, Ruschoff J, Weber D, Mannel DN (1993) Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med 177:1391-1398
56. Furukawa T, Duguid WP, Kobari M, Matsuno S, Tsao MS (1995) Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. Am J Pathol 147:889-895